Medline recalls millions of devices due to safety risk | FDA's warning about sizing catheters | Post-TAVR bleeding events

Millions of angiographic syringes were recalled due to a risk of parts becoming loose or disconnected. The FDA, unhappy with Medline's response to this situation, sent the company a new warning letter. 

These catheters from Cook Medical are associated with an increased risk of device fragmentation or vessel injury. Customers are urged to return them to the manufacturer. 

When it came to all-cause mortality and ischemic stroke, however, the two popular DOACs were associated with comparable outcomes. 

The Adams Valve Institute—named after David H. Adams, MD—plans on uniting specialists to provide high-quality care, promote innovation and advocate for policy reform.

A majority of deaths from Friedreich's ataxia are associated with heart complications. A new treatment years in the making could provide some much-needed relief.

The new nPulse nanosecond pulsed field ablation system uses five‑second applications to create lesions. It does not require catheter repositioning.

The Trilogy Transcatheter Heart Valve System is the first TAVR device approved by the FDA to treat severe aortic regurgitation. Until now, interventional cardiologists have had to settle for the off-label use of TAVR valves built for treating aortic stenosis. 

Afnan Tariq, MD, discusses early data on a passive, device-agnostic AI platform for heart failure monitoring. “When clinicians are empowered with insights and able to act earlier, you're able to have a durable impact," he said.

Lerman, who spent nearly 40 years with Mayo Clinic, was especially influential in the treatment of nonobstructive CAD. 

The filler contains hydroxylapatite microspheres, which may be visible on medical imaging. 

A Nexford University blogger set out to find the best bets for college students making career plans in healthcare. The research led to medical director in the No. 1 slot. (Wait. What?)